Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIO-RAD LABORATORIES, INC. Director's Dealing 2023

Dec 13, 2023

30786_dirs_2023-12-12_e190c203-06e5-4e50-8980-5d7078ab2bfa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2023-12-12

Reporting Person: WRIGHT DARA (EVP, President, CDG)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-12-12 Bio-Rad A Common Stock S 1200 $299.16 Disposed 1499.0776 Direct

Footnotes

F1: Includes 17.2030 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/29/2023.